Your session is about to expire
← Back to Search
Progesterone for Methamphetamine Addiction in Postpartum Women
Study Summary
This trial is testing whether a hormone called progesterone can help prevent postpartum women with methamphetamine use disorder from returning to methamphetamine use. A secondary aim is to assess whether the hormone allopregnanolone, which is increased by progesterone, is associated with reduced methamphetamine cravings.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am experiencing severe depression.I am currently using medications that contain progestin.I have not used methamphetamine in the last 4 weeks.I haven't taken any restricted drugs or supplements in the last two weeks.I have opioid use disorder but haven't used opioids in the last 4 weeks and have been on a stable medication dose for 2 weeks.I have been on stable doses of my psychiatric medications for at least 4 weeks.I have a history of severe mental health issues, including psychosis or hospitalizations.I do not speak English or Spanish.I am not taking strong medications like clarithromycin or ketoconazole.I do not have major illnesses where progesterone is not advised.
- Group 1: Progesterone Arm
- Group 2: Placebo Arm
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many people are involved in the current clinical trial?
"Affirmative, according to the information hosted on clinicaltrials.gov this medical trial is actively seeking participants. This research was first posted February 4th 2022 and has been revised as recently as April 15th 2022 with a need for 40 individuals at one site."
Are any of the participating facilities still enrolling individuals in this research study?
"Affirmative. Per the information listed on clinicaltrials.gov, this medical trial is actively seeking volunteers with its posting date of February 4th 2022 and most recent update occurring April 15th 2022. 40 participants are needed from a single location."
What pathologies does Progesterone Arm typically aid in remedying?
"Progesterone Arm has been used to treat various ailments, such as uterine hemorrhage, hormonal imbalance and endometrial hyperplasia caused by conjugated estrogen. Additionally, it can be administered as a preventative measure against recurrent spontaneous preterm birth."
What former experiments have focused on the Progesterone Arm?
"Currently, the landscape of clinical trials for Progesterone Arm is comprised of 42 distinct studies; 8 are in their terminal phase. Of these experiments, 268 different sites across the world offer participation - many being located in Barcelona, Catalunya."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger